IFP Advisors’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.79K Sell
51
-31
-38% -$982 ﹤0.01% 4275
2026
Q2
$1.93K Buy
82
+61
+290% +$1.26K ﹤0.01% 4249
2026
Q1
$361 Buy
21
+19
+950% +$391 ﹤0.01% 4498
2025
Q4
$47 Hold
2
– – ﹤0.01% 4713
2025
Q3
$63 Buy
+2
New +$60 ﹤0.01% 4622
2025
Q2
– Hold
0
– – – 4789

Other funds holding SMTI

IFP Advisors's SMTI Position: Q3 2026 in Review

IFP Advisors reduced its Sanara MedTech (SMTI) stake by 38% in Q3 2026, selling an estimated $982 and leaving 51 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #4275.

IFP Advisors first reported a position in SMTI in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.93K in Q2 2026. 36 funds tracked by Wall St. Rank hold SMTI as of Q3 2026.

  • IFP Advisors held 51 shares of Sanara MedTech worth $1.79K as of Q3 2026.
  • IFP Advisors sold 31 Sanara MedTech shares in Q3 2026, an estimated $982.
  • Sanara MedTech made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4275 holding.
  • IFP Advisors first reported a position in Sanara MedTech in Q3 2025 and has held it in 5 quarters since.
  • IFP Advisors's Sanara MedTech position peaked at $1.93K in Q2 2026.
  • 36 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.